These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6170963)

  • 1. Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.
    Wright GL; Schellhammer PF; Faulconer RJ; Reid JW; Brassil DN; Sieg SM
    Prostate; 1981; 2(2):121-31. PubMed ID: 6170963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
    Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
    Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity in prostatic cancer and its diagnostic relevancy.
    Ablin RJ; Guinan PD; Bhatti RA
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):467-71. PubMed ID: 6190657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
    Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
    Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity.
    Bhatti RA; Ablin RJ; Guinan PD
    Eur J Cancer (1965); 1979 Jan; 15(1):133-6. PubMed ID: 421713
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
    Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
    Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of leukocyte migration by extracts of malignant prostatic tissue and correlation of degree of in vitro sensitization to clinical responsiveness in prostatic cancer patients.
    Ablin RJ; Bush IM; Bruns GR; John T; Sadoughi N; Guinan PD
    Urology; 1978 Mar; 11(3):289-92. PubMed ID: 565097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
    Bhatti R; Shaw M; Ray P
    Experientia; 1987 Aug; 43(8):916-7. PubMed ID: 3622734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas.
    McCoy JL; Jerome LJ; Cannon GB; Pomeroy TC; Connor RJ; Oldham RK; Weese JL; Herberman RB
    J Natl Cancer Inst; 1977 Oct; 59(4):1119-25. PubMed ID: 903991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassessment of patients with gastric cancer. Using leukocyte migration inhibition (LMI) test.
    Kojima O; Uehara Y; Majima T; Ikeda E; Nishioka B; Fujita Y; Majima S
    Gastroenterol Jpn; 1983 Aug; 18(4):303-9. PubMed ID: 6628918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune reactivity of Sinclair melanoma-bearing swine to 3 M KCl extracts of swine and human melanoma.
    Hook RR; Hamby CV; Millikan LE; Berkelhammer J; Stills HF; Oxenhandler RW
    Int J Cancer; 1983 May; 31(5):633-7. PubMed ID: 6852980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte migration inhibition in human pulmonary neoplasia.
    Vose BM; Kimber I; Moore M
    J Natl Cancer Inst; 1977 Mar; 58(3):483-8. PubMed ID: 839553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of leukocyte sensitization to tumor and embryonic tissue antigens in cancer of the large intestine].
    Novikov DK; Shmakov AP
    Vopr Onkol; 1981; 27(8):40-5. PubMed ID: 6269300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific cell-mediated immunity against human acoustic neuroma extract.
    Rasmussen N; Bendtzen K; Thomsen J; Tos M
    Acta Otolaryngol; 1982; 94(3-4):261-5. PubMed ID: 6756024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Bush IM; Guinan PD
    J Reprod Immunol; 1980 Feb; 1(5-6):337-45. PubMed ID: 7411523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Guinan PD
    Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
    Brannen GE; Coffey DS
    Cancer Treat Rep; 1977; 61(2):211-6. PubMed ID: 68825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.